What does Century Therapeutics, Inc. do?
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion…
What is Century Therapeutics, Inc.'s P/E and P/B ratio?
Century Therapeutics, Inc. has a P/E ratio of -1.7 and a P/B ratio of 1.23.
What is Century Therapeutics, Inc.'s debt-to-equity ratio?
Century Therapeutics, Inc. has a debt-to-equity ratio of 0.17.
How much does Century Therapeutics, Inc. owe compared with what it owns?
Century Therapeutics, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Century Therapeutics, Inc.'s Positivity rank?
Century Therapeutics, Inc. is ranked #3,009 of 6,774 companies globally and #1,155 of 4,000 in United States on PositoAI, with a Positivity Score of 20,943.
Does Century Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Century Therapeutics, Inc..
Where can I read the latest news about Century Therapeutics, Inc.?
Recent headlines about Century Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Century Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Century Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.